News Reader
12-18-2008, 04:21 PM
The U.S. Food and Drug Administration today approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.
More... (http://www.fda.gov/bbs/topics/NEWS/2008/NEW01929.html)
More... (http://www.fda.gov/bbs/topics/NEWS/2008/NEW01929.html)